PHIOW
Income statement / Annual
Last year (2023), Phio Pharmaceuticals Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Phio Pharmaceuticals Corp.'s net income was -$10.83 M.
See Phio Pharmaceuticals Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$21,000.00 |
$138,000.00 |
$15,000.00 |
$19,000.00 |
$34,000.00 |
$71,000.00 |
| Cost of Revenue |
$6.33 M
|
$193,000.00
|
$192,000.00
|
$183,000.00
|
$4,300.00
|
$4.33 M
|
$5.37 M
|
$5.42 M
|
$6.93 M
|
$5.68 M
|
| Gross Profit |
-$6.33 M
|
-$193,000.00
|
-$192,000.00
|
-$183,000.00
|
$16,700.00
|
-$4.19 M
|
-$5.36 M
|
-$5.40 M
|
-$6.89 M
|
-$5.61 M
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0.8
|
-30.35
|
-357
|
-284
|
-202.68
|
-79
|
| Research and Development Expenses |
$6.33 M
|
$7.01 M
|
$8.89 M
|
$4.43 M
|
$4.30 M
|
$4.33 M
|
$5.37 M
|
$5.42 M
|
$6.93 M
|
$5.68 M
|
| General & Administrative Expenses |
$4.29 M
|
$4.45 M
|
$4.63 M
|
$4.36 M
|
$4.71 M
|
$3.18 M
|
$4.01 M
|
$3.62 M
|
$3.35 M
|
$3.22 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.29 M
|
$4.45 M
|
$4.63 M
|
$4.36 M
|
$4.71 M
|
$3.18 M
|
$4.01 M
|
$3.62 M
|
$3.35 M
|
$3.22 M
|
| Other Expenses |
-$6.13 M
|
-$18,000.00
|
$224,000.00
|
-$1,000.00
|
$79,000.00
|
$4,000.00
|
$4.70 M
|
$3.11 M
|
$2.44 M
|
$2.21 M
|
| Operating Expenses |
$4.49 M
|
$11.46 M
|
$13.51 M
|
$8.79 M
|
$9.01 M
|
$7.50 M
|
$9.38 M
|
$9.03 M
|
$10.27 M
|
$8.90 M
|
| Cost And Expenses |
$10.82 M
|
$11.46 M
|
$13.51 M
|
$8.79 M
|
$9.01 M
|
$7.50 M
|
$9.38 M
|
$9.03 M
|
$10.27 M
|
$8.90 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$1.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$184,000.00
|
$193,000.00
|
$192,000.00
|
$183,000.00
|
$67,000.00
|
$81,000.00
|
$70,000.00
|
$53,000.00
|
$77,000.00
|
$87,000.00
|
| EBITDA |
-$10.64 M |
-$11.29 M |
-$13.09 M |
-$8.72 M |
-$8.92 M |
-$7.28 M |
-$14.00 M |
-$8.96 M |
-$10.16 M |
-$8.74 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
-427.95
|
-53.36
|
-310.6
|
-475.58
|
-301.03
|
-124.44
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
-427.95
|
-53.36
|
-937.47
|
-474.47
|
-301.09
|
-124.31
|
| Total Other Income/Expenses Net |
-$2,000.00
|
-$18,000.00
|
$224,000.00
|
-$1,000.00
|
$79,000.00
|
$4,000.00
|
-$11,000.00
|
$21,000.00
|
$14,000.00
|
$26,000.00
|
| Income Before Tax |
-$10.83 M
|
-$11.48 M
|
-$13.29 M
|
-$8.79 M
|
-$8.91 M
|
-$7.36 M
|
-$14.07 M
|
-$8.99 M
|
-$10.22 M
|
-$8.80 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
-424.19
|
-53.33
|
-938.2
|
-473.37
|
-300.68
|
-123.94
|
| Income Tax Expense |
$0.00
|
-$175,000.00
|
-$75,000.00
|
-$134,297.00
|
-$67,000.00
|
$4,000.00
|
-$1.62 M
|
-$74,000.00
|
-$91,000.00
|
-$113,000.00
|
| Net Income |
-$10.83 M
|
-$11.31 M
|
-$13.21 M
|
-$8.79 M
|
-$8.84 M
|
-$7.36 M
|
-$12.45 M
|
-$8.99 M
|
-$10.22 M
|
-$8.80 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
-421
|
-53.33
|
-830.13
|
-473.37
|
-300.68
|
-123.94
|
| EPS |
-46.87 |
-89.61 |
-111.32 |
-207.25 |
-2074.18 |
-6218.35 |
-32801.22 |
-79282.81 |
-93029.39 |
-238075.91 |
| EPS Diluted |
-46.76 |
-89.61 |
-111.32 |
-207.25 |
-2074.18 |
-6218.35 |
-32801.22 |
-79282.81 |
-93029.39 |
-238075.91 |
| Weighted Average Shares Out |
$231,000.00
|
$126,159.00
|
$118,684.00
|
$42,432.00
|
$4,262.40
|
$1,183.59
|
$379.62
|
$113.44
|
$109.89
|
$36.96
|
| Weighted Average Shares Out Diluted |
$231,508.00
|
$126,159.00
|
$118,684.00
|
$42,432.00
|
$4,262.40
|
$1,183.59
|
$379.62
|
$113.44
|
$109.89
|
$36.96
|
| Link |
|
|
|
|
|
|
|
|
|
|
